Trials that use: Intention-to-treat analysis
New to this method? Read the tutorial →
7,779 results
- BRANCHIndependent statistical analysis of Bare Metal Bifurcation Stent Clinical Trial in Humans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00607321).
- BRAVE-EPAIndependent statistical analysis of Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02719327).
- BRAVOComplete statistical analysis of the BRAVO phase 3 trial of laquinimod in participants with relapsing-remitting multiple sclerosis, including its annualized confirmed relapse-rate analysis, negative binomial regression methodology, confidence intervals, and statistical interpretation.
- BRAVOIndependent statistical analysis of A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO): primary endpoint results, effect estimate with…
- BRAVOIndependent statistical analysis of Buprenorphine to Improve HIV Care Engagement and Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01936857).
- Break MBIndependent statistical analysis of A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- BREAKWATERIndependent statistical analysis of the BREAKWATER phase 3 trial of encorafenib plus cetuximab with or without chemotherapy in previously untreated metastatic colorectal cancer, including trial design, primary endpoints, hazard ratios, odds ratios,…
- Breast Cancer Risk Biomarkers in Postmenopausal Women: Complete Statistical AnalysisIndependent statistical analysis of Breast Cancer Risk Biomarkers in Postmenopausal Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01252290).
- BreastCAREIndependent statistical analysis of Breast Cancer Risk Reduction: A Patient Doctor Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01830933).
- BREEZE-AD1Independent statistical analysis of A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- BretuximabIndependent statistical analysis of Brentuximab Vedotin in Patients With Relapsed or Refractory EBV-and CD30-positive Lymphomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment: Complete Statistical AnalysisIndependent statistical analysis of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD): Complete Statistical AnalysisIndependent statistical analysis of Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated With Dementia of the Alzheimer’s Type: Complete Statistical AnalysisIndependent statistical analysis of Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- BridgeIndependent statistical analysis of Maintenance of Platelet Inhibition With Cangrelor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00767507).
- BRIDGE Percutaneous Nerve Stimulation for Cesarean Delivery Pain Control: Complete Statistical AnalysisIndependent statistical analysis of BRIDGE Percutaneous Nerve Stimulation for Cesarean Delivery Pain Control: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04365465).
- Bridging the Evidence-to-practice Gap: Complete Statistical AnalysisIndependent statistical analysis of Bridging the Evidence-to-practice Gap: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03713515).
- Brief Cognitive Behavioral Therapy for Chronic Pain to Improve Functioning Among Veterans: Complete Statistical AnalysisIndependent statistical analysis of Brief Cognitive Behavioral Therapy for Chronic Pain to Improve Functioning Among Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Brief Cognitive Behavioral Therapy for Military Populations: Complete Statistical AnalysisIndependent statistical analysis of Brief Cognitive Behavioral Therapy for Military Populations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02038075).
- Brief Educational Video for Patients Prescribed LTBI Treatment: Complete Statistical AnalysisIndependent statistical analysis of Brief Educational Video for Patients Prescribed LTBI Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05412212).
- Brief Group Psychoeducation for Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Brief Group Psychoeducation for Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02911519).
- Brief Intervention for Justice-Involved Substance Users: Complete Statistical AnalysisIndependent statistical analysis of Brief Intervention for Justice-Involved Substance Users: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03308877).
- Brigatinib Before Brain Irradiation Trial (B3i Trial): Complete Statistical AnalysisIndependent statistical analysis of Brigatinib Before Brain Irradiation Trial (B3i Trial): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04634110).
- BRIGHTIndependent statistical analysis of Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) 2.0: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- BRIGHT AML1019Independent statistical analysis of A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia: primary endpoint results, effect estimate…
- BRIUS Vs FFA Efficiency: Complete Statistical AnalysisIndependent statistical analysis of BRIUS Vs FFA Efficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04347018).
- Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer: Complete Statistical AnalysisIndependent statistical analysis of Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- BROOKLYNIndependent statistical analysis of Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- BRPIndependent statistical analysis of IIT CTI Bendamustine, Rituximab, Pixantrone in Relapsed/Refractory B Cell Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- BrTK02Independent statistical analysis of Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- BRUOG-407Independent statistical analysis of Removing Transfusion Dependence as a Barrier to Hospice Enrollment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05063591).
- Bryostatin Treatment of Moderately Severe Alzheimer’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Bryostatin Treatment of Moderately Severe Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04538066).
- BSSIndependent statistical analysis of Blue Sky Study: Impact of Milk and Vitamin D for Child Growth and Health: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- BTK Inhibitor BGB-3111 in Chinese Participants With Diffuse Large B-Cell Lymphoma (Non-GCB) and Indolent Lymphoma (FL and MZL): Complete Statistical AnalysisIndependent statistical analysis of BTK Inhibitor BGB-3111 in Chinese Participants With Diffuse Large B-Cell Lymphoma (Non-GCB) and Indolent Lymphoma (FL and MZL): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- BTX-A-HAC NGIndependent statistical analysis of Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Bubble PEP Training Among Patient With Chronic Obstructive Pulmonary Disease in Pulmonary Function Effects: Complete Statistical AnalysisIndependent statistical analysis of Bubble PEP Training Among Patient With Chronic Obstructive Pulmonary Disease in Pulmonary Function Effects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Buccal Versus Vaginal Misoprostol for Third Trimester Induction of Labor: Complete Statistical AnalysisIndependent statistical analysis of Buccal Versus Vaginal Misoprostol for Third Trimester Induction of Labor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01519765).
- BudERIndependent statistical analysis of Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Buffered vs. Unbuffered Local Anesthesia in Mandibular Molars Diagnosed With Symptomatic Irreversible Pulpitis: Complete Statistical AnalysisIndependent statistical analysis of Buffered vs. Unbuffered Local Anesthesia in Mandibular Molars Diagnosed With Symptomatic Irreversible Pulpitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- buffering SLNIndependent statistical analysis of Does Alkalinization Reduce Perceived Pain Levels During Sentinel Lymph Node Imaging?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Building and Pilot Testing a Couples-based Smartphone Systems to Address Alcohol Use Disorder: Complete Statistical AnalysisIndependent statistical analysis of Building and Pilot Testing a Couples-based Smartphone Systems to Address Alcohol Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- BULLDOGIndependent statistical analysis of Comparison of Tear Evaporation Rate With Systane Complete in Dry Eye and Non-Dry Eye: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- BULLETIndependent statistical analysis of BULLET: Bladder Ultrasound Limits Length (of Time), Expedites Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03860311).
- Bundling and Unbundling the Laparoscopic Electrosurgery Cord With the Camera Cord: Complete Statistical AnalysisIndependent statistical analysis of Bundling and Unbundling the Laparoscopic Electrosurgery Cord With the Camera Cord: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Buoy Electrolyte Study on Hydration Status of Active Men and Women: Complete Statistical AnalysisIndependent statistical analysis of Buoy Electrolyte Study on Hydration Status of Active Men and Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis: Complete Statistical AnalysisIndependent statistical analysis of Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01157169).
- Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients: Complete Statistical AnalysisIndependent statistical analysis of Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00879996).
- Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users: Complete Statistical AnalysisIndependent statistical analysis of Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04995029).
- Buprenorphine Plus Baclofen to Increase Analgesia in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Buprenorphine Plus Baclofen to Increase Analgesia in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04251819).